143 related articles for article (PubMed ID: 7779733)
1. Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma.
Brada M; Thomas G; Elyan S; James N; Hines F; Ashley S; Marsh H; Bell BA; Stenning S
Br J Cancer; 1995 Jun; 71(6):1330-4. PubMed ID: 7779733
[TBL] [Abstract][Full Text] [Related]
2. Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration.
Brada M; Sharpe G; Rajan B; Britton J; Wilkins PR; Guerrero D; Hines F; Traish D; Ashley S
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):287-92. PubMed ID: 10030251
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma.
Thomas R; James N; Guerrero D; Ashley S; Gregor A; Brada M
Radiother Oncol; 1994 Nov; 33(2):113-6. PubMed ID: 7535939
[TBL] [Abstract][Full Text] [Related]
4. A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma.
Ford JM; Stenning SP; Boote DJ; Counsell R; Falk SJ; Flavin A; Laurence VM; Bleehen NM
Clin Oncol (R Coll Radiol); 1997; 9(1):20-4. PubMed ID: 9039809
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated radiotherapy for poor prognosis malignant glioma: matched pair survival analysis with MRC controls.
McAleese JJ; Stenning SP; Ashley S; Traish D; Hines F; Sardell S; Guerrero D; Brada M
Radiother Oncol; 2003 May; 67(2):177-82. PubMed ID: 12812848
[TBL] [Abstract][Full Text] [Related]
6. The effect of waiting for radiotherapy for grade III/IV gliomas.
Do V; Gebski V; Barton MB
Radiother Oncol; 2000 Nov; 57(2):131-6. PubMed ID: 11054516
[TBL] [Abstract][Full Text] [Related]
7. Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme.
Nieder C; Nestle U; Ketter R; Kolles H; Gentner SJ; Steudel WI; Schnabel K
Radiat Oncol Investig; 1999; 7(1):36-41. PubMed ID: 10030622
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
9. Supratentorial low-grade glioma: results and prognostic factors following postoperative radiotherapy.
Grabenbauer GG; Roedel CM; Paulus W; Ganslandt O; Schuchardt U; Buchfelder M; Schrell U; Fahlbusch R; Huk WJ; Sauer R
Strahlenther Onkol; 2000 Jun; 176(6):259-64. PubMed ID: 10897252
[TBL] [Abstract][Full Text] [Related]
10. UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas. United Kingdom Childhood Cancer Study Group.
Lewis J; Lucraft H; Gholkar A
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):925-9. PubMed ID: 9276356
[TBL] [Abstract][Full Text] [Related]
11. Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial.
Fitzek MM; Thornton AF; Harsh G; Rabinov JD; Munzenrider JE; Lev M; Ancukiewicz M; Bussiere M; Hedley-Whyte ET; Hochberg FH; Pardo FS
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):131-7. PubMed ID: 11516862
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
[TBL] [Abstract][Full Text] [Related]
13. Accelerated hyperfractionated radiotherapy for malignant gliomas.
Buatti JM; Marcus RB; Mendenhall WM; Friedman WA; Bova FJ
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):785-92. PubMed ID: 8598354
[TBL] [Abstract][Full Text] [Related]
14. [The role of age and tumor grade in the choice of fractionation regimen in patients with high-grade gliomas].
Izmaĭlov TR; Pan'shin GA; Datsenko PV
Vopr Onkol; 2012; 58(3):374-9. PubMed ID: 22888654
[TBL] [Abstract][Full Text] [Related]
15. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
16. High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison.
Tanaka M; Ino Y; Nakagawa K; Tago M; Todo T
Lancet Oncol; 2005 Dec; 6(12):953-60. PubMed ID: 16321763
[TBL] [Abstract][Full Text] [Related]
17. Treatment of malignant gliomas in the elderly.
Pierga JY; Hoang-Xuan K; Feuvret L; Simon JM; Cornu P; Baillet F; Mazeron JJ; Delattre JY
J Neurooncol; 1999 Jun; 43(2):187-93. PubMed ID: 10533732
[TBL] [Abstract][Full Text] [Related]
18. Comparison of accelerated hyperfractionated radiotherapy and conventional radiotherapy for supratentorial malignant glioma.
Shibamoto Y; Nishimura Y; Tsutsui K; Sasai K; Takahashi M; Abe M
Jpn J Clin Oncol; 1997 Feb; 27(1):31-6. PubMed ID: 9070338
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review.
Laperriere N; Zuraw L; Cairncross G;
Radiother Oncol; 2002 Sep; 64(3):259-73. PubMed ID: 12242114
[TBL] [Abstract][Full Text] [Related]
20. Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02.
Murray KJ; Nelson DF; Scott C; Fischbach AJ; Porter A; Farnan N; Curran WJ
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):453-9. PubMed ID: 7852106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
